Abstract
Poisonings in pediatrics remains a consistent cause for presentation to emergency departments. According to the 2016 34th annual report of the American Association of Poison Control Centers’, children <3 years of age accounted for 34.7% of all exposures and children ≤5 years of age accounted for 50% of all exposures. The top three most common poisonings were analgesics, household cleaning substances, and cosmetics/personal care products. Overall, compared to the 2015 data, there was an overall decline in number of reported fatalities in children <20 years old. In children <6 years of age, there were 24 reported deaths. Most common causes were fumes/gases/vapors. Among children between 6 and 12 years old, there were seven reported deaths with the most common cause listed as analgesic exposure. In adolescents aged 13–19 years old, there were 42 reported fatalities with the most common cause listed as analgesics [1] (see Table 21.2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gummin DD, et al. 2016 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol (Phila). 2017;55(10):1072–252.
Rademacher S, Oppert M, Jorres A. Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol. 2011;5(5):591–9.
Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI. Management of a Severe Carbamazepine Overdose Using Albumin-Enhanced Continuous Venovenous Hemodialysis. Pediatrics. 2004;133(2):406–9.
Churchwell MD, Pasko DA, Smoyer WE, Mueller BA. Enhanced clearance of highly protein bound drugs by albumin supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant. 2009;24:231–8.
Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol. 2008;23:1013–6.
Mitzner SR, Stange J. Albumin dialysis with molecular adsorbent recirculating system in the treatment of liver failure. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 1539–43.
Harbord N, Feinfeld DA, Winchester JF. Hemodialysis, hemofiltration, and hemoperfusion in acute intoxication and poisoning. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 919–25.
Kumar PP, et al. Charcoal hemoperfusion for phenytoin intoxication. Indian Pediatr. 2012;49(2):152–3.
Shalkham AS, et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis. 2006;48(2):239–41.
Nemoto T, et al. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure. Pediatr Hematol Oncol. 2009;26(7):520–5.
Borkan SC. Extracorporeal therapies for acute intoxications. Crit Care Clin. 2002;18:393–420.
Misanovic V, et al. Plasmapheresis in pediatric intensive care unit. Med Arch. 2016;70(5):332–5.
Nenov VD, Marinov P, Sabeva J, Nenov DS. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant. 2003;18(Suppl 5):v56–8.
Cox RD, Phillips WJ. Ethylene glycol toxicity. Mil Med. 2004;169(8):660–3.
Kuang D, Ronco C, NA H. Poisoning: kinetics to therapeutics. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 931–54.
Wiley JF. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999;11(3):269–73.
Jacobsen D, Hovda KE. Methanol, ethylene glycol, and other toxic alcohols. In: Haddad and Winchester’s clinical management of poisoning and drug overdose. Philadelphia: Saunders; 2007. p. 605–21.
Goldfrank LR, et al. Goldfrank’s toxicologic emergencies. 8th ed. New York: McGraw Hill; 2006.
Tadokoro M, et al. A case of acute renal failure due to ethylene glycol intoxication. Nihon Jinzo Gakkai Shi. 1995;37(6):353–6.
Schwerk N, et al. Successful therapy of paediatric ethylene glycol poisoning: a case report and annual survey by a regional poison centre. Acta Paediatr. 2007;96(3):461–3.
Litovitz T. The alcohols: ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin N Am. 1986;33(2):311–23.
Stapenhorst L, Hesse A, Hoppe B. Hyperoxaluria after ethylene glycol poisoning. Pediatr Nephrol. 2008;23(12):2277–9.
Brent J. Current management of ethylene glycol poisoning. Drugs. 2001;61(7):979–88.
Hirsch DJ, et al. A simple method to estimate the required dialysis time for cases of alcohol poisoning. Kidney Int. 2001;60(5):2021–4.
Brent J. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol (Phila). 2010;48(5):401–6.
Loza R, Rodriguez D. A case of methanol poisoning in a child. Case Rep Nephrol. 2014;2014:652129.
Barceloux DG, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415–46.
Sutton TL, Foster RL, Liner SR. Acute methanol ingestion. Pediatr Emerg Care. 2002;18(5):360–3.
Roberts DM, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med. 2015;43(2):461–72.
Brown MJ, et al. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001;108(4):E77.
Gibson PJ, Cant AJ, Mant TG. Ethanol poisoning. Acta Paediatr Scand. 1985;74(6):977–8.
Gormley NJ, et al. The rising incidence of intentional ingestion of ethanol-containing hand sanitizers. Crit Care Med. 2012;40(1):290–4.
Slaughter RJ, et al. Isopropanol poisoning. Clin Toxicol (Phila). 2014;52(5):470–8.
Church AS, Witting MD. Laboratory testing in ethanol, methanol, ethylene glycol, and isopropanol toxicities. J Emerg Med. 1997;15(5):687–92.
Wiener SW. Toxic alcohol. In: Goldfrank’s Toxicologic emergencies. New York: McGraw-Hill; 2014. p. 1346–53.
Stremski E, Hennes H. Accidental isopropanol ingestion in children. Pediatr Emerg Care. 2000;16(4):238–40.
Baird-Gunning J, et al. Lithium poisoning. J Intensive Care Med. 2017;32(4):249–63.
Decker BS, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2015;10(5):875–87.
Bruns AS, Sebestyen J. Twelve-year-old female with nausea, vomiting, edema, tremor, and slurred speech. Clin Pediatr (Phila). 2015;54(2):194–6.
McLean MM, et al. A 17-year-old female patient with a Lithium overdose. Air Med J. 2015;34(4):162–5.
Meyer RJ, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis. 2001;37(5):1044–7.
Groleau G. Lithium toxicity. Emerg Med Clin North Am. 1994;12(2):511–31.
Fischbach M, et al. Hemodialysis in children: general practical guidelines. Pediatr Nephrol. 2005;20(8):1054–66.
Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367(26):2505–14.
Ogilvie JD, Rieder MJ, Lim R. Acetaminophen overdose in children. CMAJ. 2012;184(13):1492–6.
Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005;17(2):239–45.
Shannon M, Borron S, Burns M. Haddad and Winchester’s clinical management of poisoning and drug overdose. Philadelphia: Saunders; 2007. p. 825–31.
Keays R, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026–9.
Squires RH, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8.
Ghannoum M, et al. Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clin Toxicol (Phila). 2016;54(6):519–22.
Mirrakhimov AE, et al. The role of renal replacement therapy in the management of pharmacologic poisonings. Int J Nephrol. 2016;2016:3047329.
Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. 2002;19(3):206–9.
Rivera W, et al. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother. 2004;38(7–8):1186–8.
Lugassy D. Salicylates. In: Hoffman R, Howland M, Lewin N, Nelson L, Goldfrank L, editors. Goldfrank’s toxicologic emergencies. New York: McGraw-Hill; 2015.
Juurlink DN, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66(2):165–81.
Muniandy RK, Sinnathamby V. Salicylate toxicity from ingestion of traditional massage oil. BMJ Case Rep. 2012;2012. https://doi.org/10.1136/bcr-2012-006562.
Papacostas MF, et al. Use of continuous renal replacement therapy in salicylate toxicity: a case report and review of the literature. Heart Lung. 2016;45(5):460–3.
Fisher J, Graudins A. Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity. J Med Toxicol. 2015;11(3):359–63.
Ghannoum M, et al. Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53(4):215–29.
Ma YJ, et al. Theophylline: a review of population pharmacokinetic analyses. J Clin Pharm Ther. 2016;41(6):594–601.
Yaman A, et al. Severe theophylline poisoning treated with continuous venovenous hemodialysis in a child. Turk J Pediatr. 2016;58(3):297–300.
Mactier R, et al. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP workgroup. Am J Kidney Dis. 2014;64(3):347–58.
Söylemezoğlu O, et al. Haemodialysis treatment in phenobarbital intoxication in infancy. Int Urol Nephrol. 1993;25(1):111–3.
Kihtir HS, et al. Single-pass albumin dialysis in a child aged six months with phenobarbital poisoning. Turk Pediatri Ars. 2016;51(4):228–30.
Goktas U, Kati I, Yuce HH. Management of a severe carbamazepine overdose with continuous venovenous hemodiafiltration. Am J Emerg Med. 2010;28(2):260.e1–2.
Ghannoum M, et al. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(10):993–1004.
Yildiz TS, et al. Continuous venovenous hemodiafiltration to treat controlled-release carbamazepine overdose in a pediatric patient. Paediatr Anaesth. 2006;16(11):1176–8.
Anseeuw K, et al. Extracorporeal treatment in phenytoin poisoning: systematic review and recommendations from the EXTRIP (extracorporeal treatments in poisoning) workgroup. Am J Kidney Dis. 2016;67(2):187–97.
Fischer JH, Patel TV, Fischer PA. Fosphenytoin clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42:33–58.
Singh S, Rathore S, Verma DK, Kumar P, Bhatia BD. Tandem plasmapheresis with hemodialysis in phenytoin intoxication: a case report. Int J Adv Med. 2015;2(3):269–71.
Dönmez O, Cetinkaya M, Canbek R. Hemoperfusion in a child with amitriptyline intoxication. Pediatr Nephrol. 2005;20(1):105–7.
Presley JD, Chyka PA. Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Ann Pharmacother. 2013;47(5):735–43.
Mutlu M, et al. Charcoal hemoperfusion in an infant with supraventricular tachycardia and seizures secondary to amitriptyline intoxication. Hum Exp Toxicol. 2011;30(3):254–6.
Bek K, et al. Charcoal haemoperfusion in amitriptyline poisoning: experience in 20 children. Nephrology (Carlton). 2008;13(3):193–7.
Karaci M, et al. Severe childhood amitriptyline intoxication and plasmapheresis: a case report. Turk J Pediatr. 2013;55(6):645–7.
Kolsal E, Tekin I, Cumhur A, Akyuz M, Cabuk H, Eldes N, Numanoglu V. Treatment of severe amitriptyline intoxication with plasmapheresis. J Clin Apher. 2009;24:21–4.
Ghannoum M, et al. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53(5):454–65.
Thanacoody RH. Extracorporeal elimination in acute valproic acid poisoning. Clin Toxicol (Phila). 2009;47(7):609–16.
Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm. 2012;69(1):35–9.
Tsai MF, Chen CY. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis. Ren Fail. 2008;30(8):822–4.
Dharnidharka VR, Fennell RS, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol. 2002;17(5):312–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Raina, R., Lam, S., Raheja, H., Bestic, M., Blackford, M. (2019). Management of Intoxications in Pediatrics. In: Sethi, S., Raina, R., McCulloch, M., Bunchman, T. (eds) Critical Care Pediatric Nephrology and Dialysis: A Practical Handbook. Springer, Singapore. https://doi.org/10.1007/978-981-13-2276-1_21
Download citation
DOI: https://doi.org/10.1007/978-981-13-2276-1_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2275-4
Online ISBN: 978-981-13-2276-1
eBook Packages: MedicineMedicine (R0)